Though it has risks, Palforzia relieves anxiety, families say
The first treatment for peanut allergy has won approval from the Food and Drug Administration. The drug, Palforzia, will list for $890 a month and brings its own risks, the Wall Street Journal
reports. And the treatment, approved for those ages 4 to 17, won't make it possible for...